Received 07/05/2022 review began 08/26/2022 review ended 09/10/2022 published 09/20/2022

HIGHLIGHTS

  • who: Newly Discovered Cutting-Edge Triple and colleagues from the California Institute of and, USA Obstetrics and Gynecology, California have published the research: Received 07/05/2022 Review began 08/26/2022 Review ended 09/10/2022 Published 09/20/2022, in the Journal: (JOURNAL) of April/24,/2022
  • what: The development of triple therapy has undoubtedly revolutionized the treatment of CF patients.
  • future: There remains a sizeable minority of patients who do not qualify for/cannot obtain these medications which provides future research objectives for CF researchers.

SUMMARY

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?